Table 4

Bronchopulmonary dysplasia: high frequency ventilation (HFV) versus conventional ventilation (CV)

ReferenceHFV event observed/ total No of patientsCV event observed /total No of patientsRelative risk (95% CI)
Froese, 19870/62/90.29 (0.02, 5.08)
HIFI, 1989130/327141/3460.98 (0.81, 1.17)
Carlo, 19907/187/160.89 (0.04, 1.98)
Clark, 19929/3017/260.46 (0.25, 0.85)
Ogawa, 199317/4615/461.13 (0.65, 1.99)
Gerstmann, 199615/6427/610.53 (0.31, 0.89)
Wiswell, 199621/3723/360.89 (0.61, 1.29)
Keszler, 199737/5537/520.95 (0.73, 1.22)
Rettwitz-Volk, 199818/2114/201.22 (0.88, 1.71)
Total for all studies254/604283/6120.90 (0.80, 1.02)
Total for HLVS subgroup96/216110/2050.83 (0.69, 0.99)
Total for surfactant subgroup108/223116/2150.89 (0.75, 1.06)
Total for HFOV subgroup189/494216/5080.90 (0.77, 1.04)
Total for HFJV subgroup65/11067/1040.92 (0.75, 1.13)
  • HFV=high frequency ventilation; HFOV=high frequency oscillatory ventilation; HFJV=high frequency jet ventilation; CV=conventional ventilation; RDS=respiratory distress syndrome; BPD=bronchopulmonary dysplasia; CLD=chronic lung disease; HLVS=high lung volume strategy; RR=relative risk; CI=confidence interval.